ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

Xenotransplantation

Xenotransplantation

Volume 14 Issue 4, Pages 345 - 346

Published Online: 28 Jul 2007

© 2009 John Wiley & Sons A/S



< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  Full Text: HTML, PDF (Size: 446K)  | Related Articles | Citation Tracking

Brief Communication
National policies for xenotransplantation in the USA*
Eda T. Bloom
Gene Transfer and Immunogenicity Branch, Division of Cellular and Gene Therapies, Office of Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD, USA
Correspondence to Address reprint requests to Eda T. Bloom, Gene Transfer and Immunogenicity Branch (HFM-725), Division of Cellular and Gene Therapies, Office of Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, USA (E-mail: eda.bloom@fda.hhs.gov)

  *Based on a presentation to a satellite symposium Xenotransplantation – Current Standards for Clinical Trials held in conjunction with the World Transplant Congress, Boston, 2006.

Copyright 2007 Blackwell Munksgaard
Bloom ET. National policies for xenotransplantation in the USA. Xenotransplantation 2007; 14: 345–346. © Blackwell Munksgaard, 2007

ABSTRACT

Abstract: An overview of xenotransplantation regulatory policies in the USA was presented at the Satellite Symposium, ''Xenotransplantation – Current Standards for Clinical Trials,'' held in conjunction with the World Transplant Congress, Boston, MA, USA 2006. This article summarizes that overview.


Received 2 March 2007; Accepted 13 March 2007

DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1399-3089.2007.00396.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Latest News & Information
XEN Impact Factor

ATC
Sign Up Now

Sign Up Now

Be the first to know about new research in your field

Sign up for FREE e-alerts from Wiley-Blackwell journals!

Sign Up Now